Postnatal metabolic and reproductive consequences of fetal and neonatal exposure to the smoking cessation drug bupropion.


INTRODUCTION In all, 10% to 20% of all pregnant women smoke despite intentions to quit. Smoking cessation drugs such as nicotine replacement therapy (NRT) and bupropion are recommended for pregnant women. Our observation that developmental exposure to nicotine adversely affects metabolic and reproductive outcomes in rats has raised concerns about NRT's… (More)
DOI: 10.1177/1933719113477493


3 Figures and Tables

Slides referencing similar topics